Literature DB >> 15474713

Comparison of varicella history with presence of varicella antibody in refugees.

Demian Christiansen1, Elizabeth D Barnett.   

Abstract

OBJECTIVE: To compare history of varicella with presence of varicella antibody in refugees and to determine the number of unnecessary doses of varicella vaccine administered to refugee children > or =7 years of age.
METHODS: Cross-sectional study of refugees > or =7 years of age evaluated between July 2000 and October 2002 by the Refugee Health Assessment Program at Boston Medical Center. We recorded age, sex, region of origin, varicella history, and results of serologic testing for presence of varicella antibodies.
RESULTS: Eighty-eight percent of individuals with a positive history of clinical varicella had varicella antibody; 65% of those with negative history had varicella antibody. The positive predictive value of a history of clinical varicella was 88%. The negative predictive value of a negative history was 39%.
CONCLUSION: History of varicella was not a reliable predictor of presence or absence of varicella antibody in refugees. Strategies to protect individuals with negative histories of clinical varicella include immediate immunization or serotesting followed by immunization of susceptible individuals. Relying on positive histories of clinical varicella may leave some individuals susceptible to varicella and impede efforts to eliminate varicella in the US.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15474713     DOI: 10.1016/j.vaccine.2004.04.024

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  11 in total

1.  Evidence-based clinical guidelines for immigrants and refugees.

Authors:  Kevin Pottie; Christina Greenaway; John Feightner; Vivian Welch; Helena Swinkels; Meb Rashid; Lavanya Narasiah; Laurence J Kirmayer; Erin Ueffing; Noni E MacDonald; Ghayda Hassan; Mary McNally; Kamran Khan; Ralf Buhrmann; Sheila Dunn; Arunmozhi Dominic; Anne E McCarthy; Anita J Gagnon; Cécile Rousseau; Peter Tugwell
Journal:  CMAJ       Date:  2010-06-07       Impact factor: 8.262

2.  Risk Factors for Varicella Susceptibility Among Refugees to Toronto, Canada.

Authors:  Geneviève Cadieux; Vanessa Redditt; Daniela Graziano; Meb Rashid
Journal:  J Immigr Minor Health       Date:  2017-02

3.  Health status of newly arrived refugees in Toronto, Ont: Part 1: infectious diseases.

Authors:  Vanessa J Redditt; Praseedha Janakiram; Daniela Graziano; Meb Rashid
Journal:  Can Fam Physician       Date:  2015-07       Impact factor: 3.275

Review 4.  Pathogenesis of varicelloviruses in primates.

Authors:  Werner J D Ouwendijk; Georges M G M Verjans
Journal:  J Pathol       Date:  2015-01       Impact factor: 7.996

5.  Serological Susceptibility to Varicella Among U.S. Immigration and Customs Enforcement Detainees.

Authors:  Aiden K Varan; Edith R Lederman; Shanon S Stous; Diana Elson; Jennifer L Freiman; Mona Marin; Adriana S Lopez; William M Stauffer; Rachael H Joseph; Stephen H Waterman
Journal:  J Correct Health Care       Date:  2017-09-25

6.  New faces from faraway places: Immigrant child health in Canada.

Authors:  Maryanne Crockett
Journal:  Paediatr Child Health       Date:  2005-05       Impact factor: 2.253

7.  Assessing adherence to accepted national guidelines for immigrant and refugee screening and vaccines in an urban primary care practice: a retrospective chart review.

Authors:  Barbara Waldorf; Christopher Gill; Sondra S Crosby
Journal:  J Immigr Minor Health       Date:  2014-10

8.  Seroprevalence of varicella-zoster virus in five US-bound refugee populations.

Authors:  Jessica Leung; Adriana Lopez; Tarissa Mitchell; Michelle Weinberg; Deborah Lee; Martha Thieme; D Scott Schmid; Stephanie R Bialek
Journal:  J Immigr Minor Health       Date:  2015-02

Review 9.  Application of Oral Fluid Assays in Support of Mumps, Rubella and Varicella Control Programs.

Authors:  Peter A C Maple
Journal:  Vaccines (Basel)       Date:  2015-12-09

10.  Validity of a reported history of chickenpox in targeting varicella vaccination at susceptible adolescents in England.

Authors:  Nigel Field; Gayatri Amirthalingam; Pauline Waight; Nick Andrews; Shamez N Ladhani; Albert Jan van Hoek; Peter A C Maple; Kevin E Brown; Elizabeth Miller
Journal:  Vaccine       Date:  2013-07-16       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.